Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow transplantation …
J Serrano, J Roman, J Sanchez… - Blood, The Journal …, 2000 - ashpublications.org
We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210 (BCR-ABL) and p190 (BCR-ABL) after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - …, 2000 - pubmed.ncbi.nlm.nih.gov
We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
[PDF][PDF] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - BLOOD, 2000 - Citeseer
Although allogeneic bone marrow transplantation (BMT) may cure 50% to 60% of patients
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210 (BCR-ABL) and p190 (BCR-ABL) after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - Blood, 2000 - europepmc.org
We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
[PDF][PDF] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - BLOOD, 2000 - academia.edu
Although allogeneic bone marrow transplantation (BMT) may cure 50% to 60% of patients
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
[引用][C] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210^< BCR-ABL> and p190^< BCR-ABL> after allogeneic bone …
J SERRANO - Blood, 2000 - cir.nii.ac.jp
Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of
p210^<BCR-ABL> and p190^<BCR-ABL> after allogeneic bone marrow transplantation for …
p210^<BCR-ABL> and p190^<BCR-ABL> after allogeneic bone marrow transplantation for …
[HTML][HTML] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone …
J Serrano, J Roman, J Sanchez, A Jimenez… - Blood, 2000 - Elsevier
We studied lineage-specific chimerism and minimal residual disease (MRD) in sequential
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
posttransplant samples from 55 patients who underwent unmanipulated (n= 44) or partially T …
[PDF][PDF] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - BLOOD, 2000 - academia.edu
Although allogeneic bone marrow transplantation (BMT) may cure 50% to 60% of patients
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
[PDF][PDF] Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow …
J Serrano, J Roman, J Sanchez, A Jimenez… - BLOOD, 2000 - Citeseer
Although allogeneic bone marrow transplantation (BMT) may cure 50% to 60% of patients
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
with chronic myeloid leukemia (CML), disease relapse still represents the major cause of …
[引用][C] Molecular analysis of lineage-specific chimerism and minimal resudual disese by RT-PCR of p210 (BCR-ABL) and p190 (BCR-ABL) after allogeneic bone …
J SERRANO - Blood., 2000 - cir.nii.ac.jp
Molecular analysis of lineage-specific chimerism and minimal resudual disese by RT-PCR of
p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic …
p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic …